Inventor · Tervuren, BE

Kenneth Alan Simmen

26Patents
7h-index
39Co-inventors
65Inventor score

Filing activity: Mar 27, 2006 → Mar 9, 2017

Most-cited inventions

PatentTitleAreaCited byStatus
US8022077B2 Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof Human Necessities 29 Expired
US8030318B2 Fused bicyclic inhibitors of HCV Human Necessities 28 Expired
US8148399B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 20 Active
US8349869B2 Macrocylic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 12 Active
US7659245B2 Macrocylic inhibitors of hepatitis C virus Chemistry; Metallurgy 12 Active
US7989471B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 9 Active
US7977342B2 HCV inhibiting bi-cyclic pyrimidines Emerging Cross-Sectional Technologies 8 Active
US8153800B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 7 Active
US8012939B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 7 Active
US7666834B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 6 Active
US9290502B2 Pteridines useful as HCV inhibitors and methods for the preparation thereof Emerging Cross-Sectional Technologies 2 Active
US9023808B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 1 Active
US8741926B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 1 Active
US8227407B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 1 Active
US8754105B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 0 Active
US8754116B2 Macrocyclic inhibitors of hepatitis C virus Chemistry; Metallurgy 0 Active
US9987277B2 Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C Human Necessities 0 Active
US9951075B2 Pteridines useful as HCV inhibitors and methods for the preparation thereof Emerging Cross-Sectional Technologies 0 Active
US9856265B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 0 Active
US9353103B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 0 Active
US8183277B2 Macrocylic inhibitors of hepatitis C virus Chemistry; Metallurgy 0 Active
US9708328B2 Pteridines useful as HCV inhibitors and methods for the preparation thereof Emerging Cross-Sectional Technologies 0 Active
US9040562B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 0 Active
US9623022B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 0 Active
US8754106B2 Macrocyclic inhibitors of hepatitis C virus Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.